Introduction: In patients with end-stage kidney disease (ESKD), the diagnosis of tuberculosis is extremely difficult due to the lack of a classical clinical and radiological picture of the tuberculosis process, oligobacillarity and anergy of tuberculin skin tests (TST). Now, studies of the efficiency of the quantiferon test among immunocompromised populations are being conducted worldwide, but there is very little information about efficiency of this test in patients with ESKD. Aim of study. To study the value of the quantiferon test in the complex diagnosis of respiratory tuberculosis in patients with ESKD. Materials and Methods: Immunological studies (quantiferon test and tuberculin skin test) were performed in 23 pts. with ESKD who applied to the Central TB Research Institute to clarify the diagnosis since 2010 until 2019. Changes in the lungs and/or fever in these pts. were revealed for the first time. Results: According to the results of the survey in 10 out of 23 ESKD pts. (43.5%) the diagnosis of active respiratory TB was verified. Other active respiratory diseases were diagnosed in 13/23 pts. (56.5%). Skin test showed a lower sensitivity (60%) compared to the QuantiFERON®-TB Gold Plus test (70%), while both tests were highly specific (100%) in the detection of TB in ESKD pts. For all indicators, statistical significance was determined (p <0.05). The agreement coefficient (Kappa) of the QuantiFERON®-TB Gold Plus test results with the skin test results was 0.671. Conclusions. Given the high specificity (100%) and sensitivity (70%), it is possible to consider the use of the QuantiFERON®-TB Gold Plus test as an additional method for the diagnosis of tuberculosis in ESKD pts